Tuberculosis (TB) remains the world’s deadliest infectious disease, with 10.8 million people affected in 2023—driven by poverty, undernutrition, crowded conditions, HIV, and other social determinants. At this critical moment, Jhpiego is accelerating action to end TB as a global threat by 2030 collaborating closely with ministries of health, national health systems, and social protection systems including the private sector, civil society, and local communities.

We support high-burden countries to expand access to timely diagnosis, treatment, and prevention for those most at risk through targeted active case finding, vulnerability mapping, and innovative screening methods such as AI-powered cough analysis and advanced digital tools. We explore emerging point-of-care diagnostics and non-sputum-based tests. Working together, we strengthen differentiated TB care models that substantially reduce mortality and advance integrated, community-driven approaches. These include social protection community-driven models, robust primary health care, and services related to maternal and child health, HIV, mental health, and post-TB lung care. By tackling the social and structural drivers of TB, countries and communities are transforming urgency into lasting impact for all.